Butobarbital
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Boghog (talk | contribs) at 13:31, 6 February 2022 (added chapter to book cite). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Barbiturate
Clinical data | |
---|---|
Trade names | Soneryl |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.928 |
Chemical and physical data | |
Formula | C10H16N2O3 |
Molar mass | 212.249 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Butobarbital, also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative.[2] It was developed by Poulenc Brothers (now part of Rhône Poulenc) in 1921.[3]
References
- ^ International Drug Names
- ^ Nordegren T (2002). "Butobarbital". The A-Z encyclopedia of alcohol and drug abuse. Parkland, Fla.: Brown Walker Press. p. 144. ISBN 978-1-58112-404-0.
- ^ DE 481129, "Verfahren zur Herstellung von n-Butylaethylbarbitursaeure", published 3 February 1922, issued 14 August 1929, assigned to ETS Poulenc Freres.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|